Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling

Journal of Investigative Dermatology

Volumn 129, Issue 3, 2009, Pages 742-751

  Zheng, Tao ^a,c   Oh, Min H ^a   Oh, Sun Y ^a   Schroeder, John T ^a   Glick, Adam B ^b   Zhu, Zhou ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKERATIN 5; CYTOKINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 13; INTERLEUKIN 4; TETRACYCLINE; THYMIC STROMAL LYMPHOPOIETIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CLINICAL FEATURE; CONTROLLED STUDY; ECZEMA; EOSINOPHIL; FIBROSIS; GENE; GENE CONTROL; HISTOLOGY; IMMUNE RESPONSE; LANGERHANS CELL; LYMPHOID TISSUE; MACROPHAGE; MAST CELL; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SKIN; SKIN BLOOD VESSEL; SKIN SURGERY; TRANSGENIC MOUSE; UPREGULATION; XEROSIS;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DERMATITIS; FIBROSIS; IMMUNE SYSTEM; INFLAMMATION; INTERLEUKIN-13; LEUKOCYTES, MONONUCLEAR; MAST CELLS; MICE; MICE, INBRED C57BL; PHENOTYPE; PRURITUS; SKIN; TRANSGENES;

EID: 59949089656     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.295     Document Type: Article

References (40)

1. Akdis M, Akdis CA, Weigl L, Disch R, Blaser K (1997) Skin-homing, CLA+ memory T cells are activated in atopic dermatitis and regulate IgE by an IL-13-dominated cytokine pattern: IgG4 counter-regulation by CLA-memory T cells. J Immunol 159:4611-9
2. Akei HS, Brandt EB, Mishra A, Strait RT, Finkelman FD, Warrier MR et al. (2006) Epicutaneous aeroallergen exposure induces systemic TH2 immunity that predisposes to allergic nasal responses. J Allergy Clin Immunol 118:62-9
3. Bochner BS, Klunk DA, Sterbinsky SA, Coffman RL, Schleimer RP (1995) IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol 154:799-803
4. Boguniewicz M, Leung DY (2006) 10. Atopic dermatitis. J Allergy Clin Immunol 117:S475-80
5. Chan LS, Robinson N, Xu L (2001) Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J Invest Dermatol 117:977-83
6. Chiaramonte MG, Donaldson DD, Cheever AW, Wynn TA (1999) An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J Clin Invest 104:777-85
7. Choi OH, Lee JH, Kassessinoff T, Cunha-Melo JR, Jones SV, Beaven MA (1993) Antigen and carbachol mobilize calcium by similar mechanisms in a transfected mast cell line (RBL-2H3 cells) that expresses ml muscarinic receptors. J Immunol 151:5586-95
8. Corne J, Chupp G, Lee CG, Homer RJ, Zhu Z, Chen Q et al. (2000) IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury. J Clin Invest 106:783-91
9. Diamond I, Owolabi T, Marco M, Lam C, Glick A (2000) Conditional gene expression in the epidermis of transgenic mice using the tetracycline-regulated transactivators tTA and rTA linked to the keratin 5 promoter. J Invest Dermatol 115:788-94
10. Emson CL, Bell SE, Jones A, Wisden W, McKenzie AN (1998) Interleukin (IL)-4-independent induction of immunoglobulin (Ig)E, and perturbation of T cell development in transgenic mice expressing IL-13. J Exp Med 188:399-404
11. Hamid Q, Boguniewicz M, Leung DY (1994) Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 94:870-6
12. Hijnen D, De Bruin-Weller M, Oosting B, Lebre C, De Jong E, Bruijnzeel-Koomen C et al. (2004) Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol 113:334-40
13. Homey B, Alenius H, Muller A, Soto H, Bowman EP, Yuan W et al. (2002) CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 8:157-65
14. Horie S, Okubo Y, Hossain M, Sato E, Nomura H, Koyama S et al. (1997) Interleukin-13 but not interleukin-4 prolongs eosinophil survival and induces eosinophil chemotaxis. Intern Med 36:179-85
15. Horikawa T, Nakayama T, Hikita I, Yamada H, Fujisawa R, Bito T et al. (2002) IFN-gamma-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis. Int Immunol 14:767-73
16. Jahnz-Rozyk K, Targowski T, Paluchowska E, Owczarek W, Kucharczyk A (2005) Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy 60:685-8
17. Kaburagi Y, Shimada Y, Nagaoka T, Hasegawa M, Takehara K, Sato S (2001) Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha, MIP-1beta, and eotaxin) in patients with atopic dermatitis. Arch Dermatol Res 293:350-5
18. Kaviratne M, Hesse M, Leusink M, Cheever AW, Davies SJ, McKerrow JH et al. (2004) IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent. J Immunol 173:4020-9
19. Lee CG, Link H, Baluk P, Homer RJ, Chapoval S, Bhandari V et al. (2004) Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med 10:1095-103
20. Leung DY, Boguniewicz M (2003) Advances in allergic skin diseases. J Allergy Clin Immunol 111:S805-12
21. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA (2004) New insights into atopic dermatitis. J Clin Invest 113:651-7
22. Leung DY, Hirsch RL, Schneider L, Moody C, Takaoka R, Li SH et al. (1990) Thymopentin therapy reduces the clinical severity of atopic dermatitis. J Allergy Clin Immunol 85:927-33
23. Liu X, Alexander V, Vijayachandra K, Bhogte E, Diamond I, Glick A (2001) Conditional epidermal expression of TGFbeta 1 blocks neonatal lethality but causes a reversible hyperplasia and alopecia. Proc Natl Acad Sci USA 98:9139-44
24. Liu YJ (2006) Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 203:269-73
25. Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, Hiroi J et al. (1997) Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 9:461-6
26. McGirt LY, Beck LA (2006) Innate immune defects in atopic dermatitis. J Allergy Clin Immunol 118:202-8
27. Mentink-Kane MM, Cheever AW, Thompson RW, Hari DM, Kabatereine NB, Vennervald BJ et al. (2004) IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis. Proc Natl Acad Sci USA 101:586-90
28. Nomura I, Goleva E, Howell MD, Hamid QA, Ong PY, Hall CF et al. (2003) Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 171:3262-9
29. Novak N, Kraft S, Bieer T (2003) Unraveling the mission of FcepsilonR1 on antigen-presenting cells. J Allergy Clin Immunol 111:38-44
30. Ong PY, Leung DY (2006) Immune dysregulation in atopic dermatitis. Curr Allergy Asthma Rep 6:384-9
31. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T et al. (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347:1151-60
32. Park CW, Lee BH, Han HJ, Lee CH, Ahn HK (2005) Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis. Br J Dermatol 152:1173-81
33. Purwar R, Werfel T, Wittmann M (2006) IL-13-stimulated human keratinocytes preferentially attract CD4+CCR4+ T cells: possible role in atopic dermatitis. J Invest Dermatol 126:1043-51
34. Schroeder JT, Saini S (2006) Assay methods for measurement of mediators and markers of allergic inflammation. In: Manual of Molecular and Clinical Laboratory Immunology (Detrick B, Hamilton RG, Folds JD, eds), 7th ed. ASM: Washington, DC, 964-74
35. Shimada Y, Takehara K, Sato S (2004) Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis. J Dermatol Sci 34:201-8
36. Woltmann G, McNulty CA, Dewson G, Symon FA, Wardlaw AJ (2000) Interleukin-13 induces PSGL-1/P-selectin-dependent adhesion of eosinophils, but not neutrophils, to human umbilical vein endothelial cells under flow. Blood 95:3146-52
37. Yamada H, Chihara J, Matsukura M, Yasuba H, Yudate T, Tezuka T (1996) Elevated plasma RANTES levels in patients with atopic dermatitis. J Clin Lab Immunol 48:87-91
38. Yoo J, Omori M, Gyarmati D, Zhou B, Aye T, Brewer A et al. (2005) Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J Exp Med 202:541-9
39. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J et al. (1999) Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 103:779-88
40. Zurawski G, de Vries JE (1994) Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 15:19-26